Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment .
A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
Phytother Res. 2019 May;33(5):1457-1468. doi: 10.1002/ptr.633848 patients with knee osteoarthritis were randomized to daily oral supplementation with either Boswellia serrata extract or placebo. Patients were followed over 4 months of treatment for outcome related to pain and function. After 4 months, results demonstrated significantly greater improvement in the BSE group for the Western Ontario and McMaster Universities Osteoarthritis Index, visual analog pain scores, Patient's Global Assessment of pain, and 6-minute walk test distances.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
